Evidence map›Paper›PMID 28726040›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2018

Assessing predicted age-specific breast cancer mortality rates in 27 European countries by 2020.

R Clèries, R M Rooney, M Vilardell, J A Espinàs, T Dyba, J M Borras

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06130241 (Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06130241 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?

TypeinterventionalSponsorAssiut UniversityRan2023 to 2025Enrolled30ConditionsSentinel Lymph NodeArmssentinle lymphnode biopsy
3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Investigation of the Association between Drinking Water Habits and the Occurrence of Women Breast Cancer.International journal of environmental research and public health · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Predictors and Trend in Attendance for Breast Cancer Screening in Lithuania, 2006-2014.International journal of environmental research and public health · 2019
    Article
  14. Review
  15. Long-term crude probabilities of death among breast cancer patients by age and stage: a population-based survival study in Northeastern Spain (Girona-Tarragona 1985-2004).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

R ClèriesCatalan Cancer Plan, IDIBELL, Hospital Duran i Reynals, Av. Gran Via de l'Hospitalet, 199-203-1a planta, L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain. r.cleries@iconcologia.net.ORCID http://orcid.org/0000-0002-3637-4747
R M RooneyEuropean Commission, DG Joint Research Centre, Institute for Health and Consumer Protection, Public Health-Cancer Policy Support, 21020, Ispra, Varese, Italy.
M VilardellSection Statistics from the Department of Genetics, Microbiology and Statistics, Biology Faculty, University of Barcelona, 08028, Barcelona, Spain.
J A EspinàsCatalan Cancer Plan, IDIBELL, Hospital Duran i Reynals, Av. Gran Via de l'Hospitalet, 199-203-1a planta, L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.
T DybaEuropean Commission, DG Joint Research Centre, Institute for Health and Consumer Protection, Public Health-Cancer Policy Support, 21020, Ispra, Varese, Italy.
J M BorrasCatalan Cancer Plan, IDIBELL, Hospital Duran i Reynals, Av. Gran Via de l'Hospitalet, 199-203-1a planta, L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca 2014SGR0635RTICC RD012/0036/0053
6 · The paper itself

Abstract

backgroundWe assessed differences in predicted breast cancer (BC) mortality rates, across Europe, by 2020, taking into account changes in the time trends of BC mortality rates during the period 2000-2010.

methodsBC mortality data, for 27 European Union (EU) countries, were extracted from the World Health Organization mortality database. First, we compared BC mortality data between time periods 2000-2004 and 2006-2010 through standardized mortality ratios (SMRs) and carrying out a graphical assessment of the age-specific rates. Second, making use of the base period 2006-2012, we predicted BC mortality rates by 2020. Finally, making use of the SMRs and the predicted data, we identified a clustering of countries, assessing differences in the time trends between the areas defined in this clustering.

resultsThe clustering approach identified two clusters of countries: the first cluster were countries where BC predicted mortality rates, in 2020, might slightly increase among women aged 69 and older compared with 2010 [Greece (SMR 1.01), Croatia (SMR 1.02), Latvia (SMR 1.15), Poland (SMR 1.14), Estonia (SMR 1.16), Bulgaria (SMR 1.13), Lithuania (SMR 1.03), Romania (SMR 1.13) and Slovakia (SMR 1.06)]. The second cluster was those countries where BC mortality rates level off or decrease in all age groups (remaining countries). However, BC mortality rates between these clusters might diminish and converge to similar figures by 2020.

conclusionsFor the year 2020, our predictions have shown a converging pattern of BC mortality rates between European regions. Reducing disparities, in access to screening and treatment, could have a substantial effect in countries where a non-decreasing trend in age-specific BC mortality rates has been predicted.

Indexed as

AdultAgedAge DistributionBreast NeoplasmsCluster AnalysisDatabases, FactualEuropeFemaleHumansMiddle AgedMortalityBreast cancerEuropeMortalityProjectionsScreeningTime trends

Identifiers

PMID28726040

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.